CR

Christopher Roberts

Sigma Healthcare Limited | Non-Executive Director
Dr Roberts has over 40 years of experience in the medical device industry serving a number of senior management positions. He was the former CEO of Cochlear from 2004 to 2015 and is presently a member of the Cochlear Foundation Board, Non-Executive Director of HCW Funds Management Limited, HMC Capital Partners Fund 1, Atmo Biosciences Ltd, Centenary Institute of Medical Research and Nutromics Pty Ltd. He was also the Executive Vice President of ResMed from 1992 to 2003, and a director until 2017. He was a former Chair of Research Australia from 2004 to 2010. He is member of the risk committee.

Companies and Roles

Company
Title
Tenure
Since
SIG
SIG
Sigma Healthcare Limited
  • Non-Executive Director
2yrs, 7mthOct 2023
CU6
CU6
Clarity Pharmaceuticals Ltd
  • Non-Executive Director
10yrs, 2mthMar 2016
HCW
HCW
HealthCo Healthcare and Wellness REIT
  • Non-Executive Director
4yrs, 10mthAug 2021
HMC
HMC
HMC Capital Limited
  • Non-Executive Director
1yrs, 6mthNov 2024

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
HMC
HMC
HMC Capital Limited
25/02/2613,226300,0000N/A
CU6
CU6
Clarity Pharmaceuticals Ltd
30/06/25N/A18,111,28017,080N/A
HCW
HCW
HealthCo Healthcare and Wellness REIT
30/06/25N/A1,105,259N/AN/A
SIG
SIG
Sigma Healthcare Limited
10/07/24012,014N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
HMC
HMC
HMC Capital Limited
25/02/26
Buy
8,560$2.810$24,053Conversion of securities
HMC
HMC
HMC Capital Limited
25/02/26
Exercise
8,560$2.810$24,053Conversion of securities
HMC
HMC
HMC Capital Limited
27/11/25
Issued
17,120$3.550$60,776Director remuneration
HMC
HMC
HMC Capital Limited
20/08/25
Buy
3,952$3.850$15,215Conversion of securities
HMC
HMC
HMC Capital Limited
20/08/25
Exercise
3,952$3.850$15,215Conversion of securities